OpenAI introduced GPT-Live, marking a significant update to its flagship language model line amid intensifying competition from alternative AI systems. Healthcare organizations evaluating foundation models for clinical documentation, diagnostic support, and administrative automation now face a rapidly expanding landscape with multiple vendors releasing comparable capabilities at varying price points. GPT-Live's performance characteristics and deployment options will directly impact purchasing decisions for EHR vendors, health systems planning generative AI integration, and consulting firms advising on AI vendor selection. The pace of model releases from OpenAI, Anthropic, and other developers means healthcare IT leaders must establish evaluation frameworks now to avoid obsolescence and maximize ROI on AI infrastructure investments.